These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

723 related items for PubMed ID: 12503474

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Reducing readmissions for congestive heart failure.
    Hoyt RE, Bowling LS.
    Am Fam Physician; 2001 Apr 15; 63(8):1593-8. PubMed ID: 11327436
    [Abstract] [Full Text] [Related]

  • 43. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
    Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.
    Circ Heart Fail; 2010 Sep 15; 3(5):596-605. PubMed ID: 20634483
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Anti-aldosterone therapy in severe heart failure].
    van Guldener C, Donker AJ.
    Ned Tijdschr Geneeskd; 1999 Aug 21; 143(34):1724-6. PubMed ID: 10494316
    [Abstract] [Full Text] [Related]

  • 46. [Retrospective analysis of drug treatment on inpatients with chronic heart failure].
    Ma JP, Wang L, Dang Q, Li YJ, Li XY, Zhang CZ, Li GP.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jan 21; 28(1):78-82. PubMed ID: 17575939
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group.
    Bergler-Klein J, Sochor H, Pouleur H, Pacher R, Porenta G, Glogar D.
    J Cardiovasc Pharmacol; 1994 Aug 21; 24(2):194-8. PubMed ID: 7526050
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Experience with beta blockers in heart failure mortality trials.
    Eichhorn EJ.
    Clin Cardiol; 1999 Oct 21; 22 Suppl 5():V21-9. PubMed ID: 10526700
    [Abstract] [Full Text] [Related]

  • 52. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).
    Krantz MJ, Ambardekar AV, Kaltenbach L, Hernandez AF, Heidenreich PA, Fonarow GC, Get With the Guidelines Steering Committee and Hospitals.
    Am J Cardiol; 2011 Jun 15; 107(12):1818-23. PubMed ID: 21482418
    [Abstract] [Full Text] [Related]

  • 53. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.
    Lamb DA, Eurich DT, McAlister FA, Tsuyuki RT, Semchuk WM, Wilson TW, Blackburn DF.
    Circ Cardiovasc Qual Outcomes; 2009 May 15; 2(3):228-35. PubMed ID: 20031842
    [Abstract] [Full Text] [Related]

  • 54. Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
    Weir RA, McMurray JJ, Puu M, Solomon SD, Olofsson B, Granger CB, Yusuf S, Michelson EL, Swedberg K, Pfeffer MA, CHARM Investigators.
    Eur J Heart Fail; 2008 Feb 15; 10(2):157-63. PubMed ID: 18242128
    [Abstract] [Full Text] [Related]

  • 55. [Medical management of chronic systolic heart failure].
    Galinier M.
    Rev Prat; 2010 Sep 20; 60(7):941-6. PubMed ID: 21033491
    [Abstract] [Full Text] [Related]

  • 56. Acute titration and chronic follow-up with captopril in hypertension. A one-year safety profile on combination therapy with captopril and a diuretic.
    Mahapatra D, Mahapatra RK, Yaden S, Hunter KW.
    Angiology; 1986 Dec 20; 37(12 Pt 1):865-79. PubMed ID: 2880534
    [Abstract] [Full Text] [Related]

  • 57. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G, Störk S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G, Angermann CE.
    Eur J Heart Fail; 2015 Apr 20; 17(4):442-52. PubMed ID: 25727879
    [Abstract] [Full Text] [Related]

  • 58. Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care.
    Gjesing A, Schou M, Torp-Pedersen C, Køber L, Gustafsson F, Hildebrandt P, Videbæk L, Wiggers H, Demant M, Charlot M, Gislason GH.
    Eur J Heart Fail; 2013 Jun 20; 15(6):671-8. PubMed ID: 23397577
    [Abstract] [Full Text] [Related]

  • 59. [The influence of 3-month treatment with molsidomine on structure, function and some neurohormonal parameters in patients with chronic heart failure treated with digoxin, diuretic and angiotensin converting enzyme inhibitors].
    Spring A, Jołda-Mydłowska B, Kosmala W, Witkowska M.
    Pol Merkur Lekarski; 1998 Jun 20; 4(24):315-8. PubMed ID: 9771014
    [Abstract] [Full Text] [Related]

  • 60. Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT.
    Krum H, Latini R, Maggioni AP, Anand I, Masson S, Carretta E, Ingrillì F, Pettinati G, Glazer R, Tognoni G, Cohn J.
    Int J Cardiol; 2007 Jun 25; 119(1):48-53. PubMed ID: 17049646
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.